• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种强效TAR诱饵对CEM细胞中HIV-1的抑制作用。

Inhibition of HIV-1 in CEM cells by a potent TAR decoy.

作者信息

Lee S W, Gallardo H F, Gaspar O, Smith C, Gilboa E

机构信息

Program of Molecular Biology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

出版信息

Gene Ther. 1995 Aug;2(6):377-84.

PMID:7584112
Abstract

TAR decoys are short RNA oligonucleotides, corresponding to the HIV TAR sequence, which inhibit HIV expression and replication by blocking the binding of the HIV regulatory protein Tat to the authentic TAR region. In previous studies, TAR decoys expressed from a tRNA polIII promoter were moderately effective at inhibiting HIV in isolated human T cell lines and less effective at inhibiting HIV in peripheral blood CD4+ T cells. In this study, a series of modifications was introduced into the tRNA expression cassette in order to improve their effectiveness. These modifications included the addition of sequences which are predicted to have stem-loop secondary structures and addition of a wild-type tRNA processing site. TAR decoy RNA expressed in CEM cells from modified tRNA-based expression cassettes yielded five- to 20-fold more TAR transcripts than unmodified tRNA-based expression cassettes. HIV replication, as measured by a flow cytometric method to quantify intracellular viral p24 expression, was significantly reduced in polyclonal populations of CEM cells expressing a modified tRNA-TAR transcript that contains a wild-type tRNA processing site and stem-loops 5' and 3' to the TAR sequence. Similar modifications to the tRNA expression cassette also increased the intracellular concentration of a random test oligonucleotide, indicating that this improved expression system may also be useful for antisense and ribozyme based gene inhibition strategies.

摘要

TAR诱饵是与HIV TAR序列对应的短RNA寡核苷酸,它通过阻断HIV调节蛋白Tat与天然TAR区域的结合来抑制HIV的表达和复制。在先前的研究中,由tRNA polIII启动子表达的TAR诱饵在分离的人T细胞系中对HIV的抑制作用中等,而在外周血CD4+ T细胞中对HIV的抑制作用较弱。在本研究中,对tRNA表达盒进行了一系列修饰以提高其有效性。这些修饰包括添加预计具有茎环二级结构的序列以及添加野生型tRNA加工位点。从基于修饰tRNA的表达盒在CEM细胞中表达的TAR诱饵RNA产生的TAR转录本比未修饰的基于tRNA的表达盒多5至20倍。通过流式细胞术方法定量细胞内病毒p24表达来测量,在表达含有野生型tRNA加工位点以及TAR序列5'和3'端茎环的修饰tRNA-TAR转录本的CEM细胞多克隆群体中,HIV复制显著降低。对tRNA表达盒进行类似修饰也增加了随机测试寡核苷酸的细胞内浓度,表明这种改进的表达系统也可能对基于反义核酸和核酶的基因抑制策略有用。

相似文献

1
Inhibition of HIV-1 in CEM cells by a potent TAR decoy.一种强效TAR诱饵对CEM细胞中HIV-1的抑制作用。
Gene Ther. 1995 Aug;2(6):377-84.
2
Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.由13个核苷酸的最小Rev结合域组成的强效Rev反应元件诱饵对人T细胞中1型人类免疫缺陷病毒的抑制作用。
J Virol. 1994 Dec;68(12):8254-64. doi: 10.1128/JVI.68.12.8254-8264.1994.
3
High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.利用从HIV-Tat诱导型载体表达的组合RNA诱饵对HIV复制进行高水平抑制。
Gene Ther. 1998 Dec;5(12):1665-76. doi: 10.1038/sj.gt.3300780.
4
Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells.RRE衍生序列的过表达抑制HIV-1在CEM细胞中的复制。
New Biol. 1992 Jan;4(1):66-74.
5
SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.源自SV40的载体利用组成型、条件型和聚合酶III启动子实现有效的转基因表达并抑制HIV-1。
Gene Ther. 2001 Jul;8(13):1033-42. doi: 10.1038/sj.gt.3301481.
6
Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.带有CMV-IE/HIV-TAR杂交长末端重复序列的逆转录病毒载体具有较高的基础表达水平,并可被HIV-1反式激活蛋白上调。
Gene Ther. 1995 Jun;2(4):269-78.
7
Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1.反义tat RNA与TAR诱饵组合阻断HIV-1感染:一种控制HIV-1的策略。
Gene Ther. 1994 May;1(3):208-16.
8
Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.表达反式显性Rev的基于HIV-1的慢病毒载体对人类免疫缺陷病毒1型(HIV-1)复制的抑制作用
J Virol. 2001 Apr;75(8):3590-9. doi: 10.1128/JVI.75.8.3590-3599.2001.
9
Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.Tat-人类免疫缺陷病毒的感染与复制:原代及长期人类淋巴细胞中LTR和tat突变的遗传分析
Virology. 1995 Aug 1;211(1):157-69. doi: 10.1006/viro.1995.1388.
10
Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.慢病毒转导的CD34+造血细胞来源的CD4+ T细胞中猿猴/人类免疫缺陷病毒复制的抑制
Mol Ther. 2005 Dec;12(6):1157-67. doi: 10.1016/j.ymthe.2005.07.698. Epub 2005 Sep 15.

引用本文的文献

1
Co-expression of anti-NFkappaB RNA aptamers and siRNAs leads to maximal suppression of NFkappaB activity in mammalian cells.抗NFκB RNA适体与小干扰RNA(siRNA)的共表达可导致哺乳动物细胞中NFκB活性的最大程度抑制。
Nucleic Acids Res. 2006 Mar 3;34(5):e36. doi: 10.1093/nar/gnj028.
2
Nucleic acid aptamers for target validation and therapeutic applications.用于靶点验证和治疗应用的核酸适配体。
J Biomol Tech. 2005 Sep;16(3):224-34.
3
A nucleolar TAR decoy inhibitor of HIV-1 replication.一种HIV-1复制的核仁TAR诱饵抑制剂。
Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14047-52. doi: 10.1073/pnas.212229599. Epub 2002 Oct 10.
4
Gene therapy for HIV.针对艾滋病病毒的基因疗法。
Sex Transm Infect. 2001 Apr;77(2):93-6. doi: 10.1136/sti.77.2.93.
5
Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers.靶向天然和合成tRNA引物的寡核苷酸可在体外抑制1型人类免疫缺陷病毒逆转录。
Nucleic Acids Res. 2000 Aug 15;28(16):3065-74. doi: 10.1093/nar/28.16.3065.
6
Inhibition of HIV/SIV replication by dominant negative Gag mutants.显性负性Gag突变体对HIV/SIV复制的抑制作用。
Virus Genes. 1999;18(3):197-201. doi: 10.1023/a:1008054111697.
7
Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 tat activation-response RNA decoy.一种HIV-2反式激活应答RNA诱饵对人类免疫缺陷病毒1型(HIV-1)基因表达和病毒产生的强力抑制作用
J Virol. 1999 Jun;73(6):5191-5. doi: 10.1128/JVI.73.6.5191-5195.1999.
8
The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat.正转录延伸因子B反式激活人类免疫缺陷病毒转录的能力取决于一个功能性激酶结构域、细胞周期蛋白T1和反式激活转录蛋白。
J Virol. 1998 Sep;72(9):7154-9. doi: 10.1128/JVI.72.9.7154-7159.1998.
9
Co-packaging of sense and antisense RNAs: a novel strategy for blocking HIV-1 replication.正义和反义RNA的共包装:一种阻断HIV-1复制的新策略。
Nucleic Acids Res. 1998 Jul 1;26(13):3270-8. doi: 10.1093/nar/26.13.3270.
10
A high affinity binding site for the HIV-1 nucleocapsid protein.一个针对HIV-1核衣壳蛋白的高亲和力结合位点。
Nucleic Acids Res. 1997 Mar 1;25(5):1042-9. doi: 10.1093/nar/25.5.1042.